Daniel Goldberg
Cardiovascular Disease · Rockville, MDNPI 1043248297
Payments from drug & device makers
Across 175 payments — averaging $22.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cue Health Inc.$867
- Amarin Pharma, Inc.$396
- Johnson & Johnson$291
- Merck$283
- Amgen$276
- Novartis$203
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,12278%
- Gifts$86722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cue Health Inc. | 1 | $867 |
| Amarin Pharma, Inc. | 23 | $396 |
| Johnson & Johnson | 18 | $291 |
| Merck | 13 | $283 |
| Amgen | 17 | $276 |
| Novartis | 8 | $203 |
| Inari Medical, Inc. | 1 | $202 |
| Boehringer Ingelheim | 11 | $191 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $156 |
| AstraZeneca | 12 | $150 |
| Pfizer | 9 | $139 |
| Novo Nordisk | 5 | $100 |
| Lundbeck LLC | 5 | $86 |
| Regeneron Healthcare Solutions, Inc. | 5 | $72 |
| Sanofi-aventis U.S. LLC | 5 | $64 |
| Kowa Pharmaceuticals America, Inc. | 5 | $63 |
| Cvrx, Inc. | 2 | $51 |
| Boston Scientific | 2 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Inspire Medical Systems, Inc. | 1 | $42 |
| Philips North America LLC | 2 | $37 |
| Lexicon Pharmaceuticals, Inc. | 2 | $36 |
| Edwards Lifesciences | 2 | $25 |
| Abiomed | 1 | $24 |
| Gilead | 2 | $23 |
| Arbor Pharmaceuticals, Inc. | 2 | $22 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $17 |
| American Regent | 1 | $16 |
| GE HealthCare | 1 | $14 |
| Aegerion Pharmaceuticals, Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,988 in reported general payments places this provider in the 65th percentile of 507 cardiovascular disease providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $15,831 |
| EntrestoSacubitril/Valsartan | 11 | $12,078 |
| Rosuvastatin Calcium | 50 | $1,408 |
| Atorvastatin Calcium | 48 | $1,115 |
| Metoprolol Succinate | 48 | $1,054 |
| Losartan Potassium | 28 | $325 |
| Amlodipine Besylate | 35 | $221 |
| Lisinopril | 30 | $202 |
| Metoprolol Tartrate | 11 | $111 |
| Atenolol | 11 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $139 | $15,83114 claims |
| NovartisEntresto | $203 | $12,07811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 507 cardiovascular disease providers in Maryland.
Other cardiovascular disease in Rockville
- Thomas WangRockville$602K
- Dennis FriedmanRockville$132K
- David BrillRockville$84K
- Christopher DefilippiBaltimore$9.2M
- Thorsten LeuckerBaltimore$7.1M
- Joao LimaBaltimore$5.6M
- Jeffrey ColeBaltimore$4.8M
- Carlos InceBaltimore$3M
- Paul GurbelBaltimore$2.6M
- Navin KapurBaltimore$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.